e-learning
resources
London 2016
Monday, 05.09.2016
Clinical and microbiological aspects of infections in COPD patients
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Airway glucose in COPD exacerbations
Patrick Mallia (London, United Kingdom), Jessica Webber, John Tregonning, Maria-Belen Trujillo-Torralbo, Maria Calderazzo, Richard Hewitt, Hugo Farne, Joseph Footitt, Phillip Molyneaux, Sebastian Johnston, Patrick Mallia
Source:
International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients
Session:
Clinical and microbiological aspects of infections in COPD patients
Session type:
Oral Presentation
Number:
1784
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Patrick Mallia (London, United Kingdom), Jessica Webber, John Tregonning, Maria-Belen Trujillo-Torralbo, Maria Calderazzo, Richard Hewitt, Hugo Farne, Joseph Footitt, Phillip Molyneaux, Sebastian Johnston, Patrick Mallia. Airway glucose in COPD exacerbations. Eur Respir J 2016; 48: Suppl. 60, 1784
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Cells biomarkers of bronchial brush-biopsies at COPD exacerbation
Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system
Year: 2013
Bacterial and viral microbiomes in COPD exacerbations of unidentified cause
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014
The relationship between blood eosinophils and bacterial load in COPD patients
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
The effect of cigarette smoke on key pathogens in COPD lung infection
Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections
Year: 2014
Blood eosinophils and outcomes in COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
Cytokine patterns and latent viruses in patients with severe asthma and COPD
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
Neural respiratory drive during recovery from exacerbations of COPD
Source: Annual Congress 2013 –Respiratory muscles at rest and during exercise: from physiology to clinical context
Year: 2013
Association between qPCR bacterial load and airway inflammation in COPD
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Frequency of COPD exacerbations and severity of COPD
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
Neutrophil/lymphocyte (NLR) ratio in infectious acute exacerbations of COPD (AECOPD)
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection
Source: Annual Congress 2013 –Guidelines and exacerbations
Year: 2013
Monitoring catalase activity in COPD exacerbations
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Autoreactivity and inflammatory phenotypes in patients with COPD and bronchial asthma
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016
Etiology of exacerbations in severe COPD patients with bronchial chronic colonization by pseudomonas
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Airway resistances deteriorate following spirometry in asthma and COPD patients
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016
Exacerbations and healthcare resource utilization among COPD patients in Sweden
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014
LATE-BREAKING ABSTRACT: The Guangzhou COPD exacerbation study: relationship of exacerbations with viral infections and soluble biomarkers
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Induced sputum and bronchial hyperresponsiveness in COPD patients
Source: International Congress 2014 – Airway biomarkers
Year: 2014
Relationship between COPD characteristics and airway bacterial load measured using 16S qPCR
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015
Etiological structure from sputum of patients with exacerbation of COPD
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept